Can I Get Money Before My Settlement?
Most lawsuits to recover damages for personal injuries will not settle or go to trial until one to three years after they are filed. Lawstreet Capital Solutions offers an alternative that can get you money well before your case settles. We are an industry-leading lending organization that provides advances against lawsuit settlements. In most cases, you will have your funds… Read more »
Challenges and Solutions for Plaintiffs After Amputation
The loss of a limb is something incomprehensible to people who have not experienced it. In the coming days and months, you’ll receive plenty of advice from doctors, therapists, and loved ones. But some of the most valuable guidance comes from other amputees who truly do know what you’re going through and what might help you deal with it. Go… Read more »
How Roundup Cancer Plaintiffs Can Get a Pre-Settlement Cash Advance
More than 8,000 lawsuits have been filed against Monsanto regarding the alleged carcinogenic nature of its Roundup weed killer. Recently, a California jury found in favor of a plaintiff who had applied the herbicide for years in his duties as a groundskeeper. He subsequently developed terminal non-Hodgkin’s lymphoma. The jury awarded the plaintiff, Dwayne Johnson, $39 million in compensatory damages… Read more »
How Long Does It Take to Get a Settlement From a Big Pharma Lawsuit?
Litigation is an avenue by which patients can seek justice for their injuries, but it’s certainly not swift justice. The civil litigation process is thought of in terms of months and years, not weeks. Although it is possible for some cases to settle relatively quickly, a settlement that takes two years or even longer is not unheard of. Major pharmaceutical… Read more »
Onglyza Legal Loans – Cash Advances for Plaintiffs
Bristol-Myers Squibb and AstraZeneca Pharmaceuticals are facing a wave of lawsuits in NJ state court, filed by patients who claim that they were not sufficiently warned about the increased risks of heart failure from using Onglyza. Despite its blockbuster sales in the U.S., the diabetes drug Onglyza (saxagliptin) has been associated with a slew of dangerous side effects that increase… Read more »
